Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Esophageal sensitivity refers to the physiological process by which the esophagus perceives and responds to various stimuli, including chemical (acid, bile), mechanical (distension), and thermal triggers (Fass & Tougas, 2002). In healthy individuals, this sensitivity is part of normal visceral sensation; however, in conditions like gastroesophageal reflux disease (GERD) and functional esophageal disorders, patients often exhibit esophageal hypersensitivity (Aziz et al., 2016). This hypersensitivity involves an exaggerated response to normal or sub-threshold stimuli, often mediated by peripheral sensitization of nociceptors such as Transient Receptor Potential Vanilloid 1 (TRPV1) or Acid-Sensing Ion Channels (ASICs) and central sensitization within the spinal cord or brain (Yamashita et al., 2021). While not a single molecular target itself, esophageal sensitivity is a key clinical endpoint and physiological state targeted by various pharmacological interventions, including acid suppressants and visceral neuromodulators (Dickman et al., 2007). Understanding the pathways of esophageal nociception is crucial for treating non-cardiac chest pain and refractory heartburn (Knowles & Aziz, 2009).
Pharmacological management typically involves acid suppression to reduce chemical stimuli or the use of visceral neuromodulators to alter the processing of sensory information in the peripheral and central nervous systems.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Esophageal sensitivity.